Goh et al. considered that DLAT is a subunit of the pyruvate dehydrogenase complex, and future mechanistic studies should elucidate the mode of action of DLAT in human gastric cancer, establishing DLAT as a viable drug target [26]. Here, DLAT is linked to gastric cancer.